Ross C. Donehower - Publications, H-index & Citations

Ross C. Donehower

Johns Hopkins University

74H指数

303论文数

3.6W被引数

收录论文 44

发表时间

Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017

CANCER LETTERS

IF10.1

2021-01-01

OAAI

Ding, Ding; Javed, Ammar A.; Cunningham, Dea; Teinor, Jonathan; Wright, Michael; Javed, Zunaira N.; Wilt, Cara; Parish, Lindsay; Hodgin, Mary; Ryan, Amy; Judkins, Carol; McIntyre, Keith; Klein, Rachel; Azad, Nilo; Lee, Valerie; Donehower, Ross; De Jesus-Acosta, Ana; Murphy, Adrian; Le, Dung T.; Shin, Eun Ji; Lennon, Anne Marie; Khashab, Mouen; Singh, Vikesh; Klein, Alison P.; Roberts, Nicholas J.; Hacker-Prietz, Amy; Manos, Lindsey; Walsh, Christi; Groshek, Lara; Brown, Caitlin; Yuan, Chunhui; Blair, Alex B.; Groot, Vincent; Gemenetzis, Georgios; Yu, Jun; Weiss, Matthew J.; Burkhart, Richard A.; Burns, William R.; He, Jin; Cameron, John L.; Narang, Amol; Zaheer, Atif; Fishman, Elliot K.; Thompson, Elizabeth D.; Anders, Robert; Hruban, Ralph H.; Jaffee, Elizabeth; Wolfgang, Christopher L.; Zheng, Lei; Laheru, Daniel A.

An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer

THYROID

IF6.7

2020-09-01

OAAI

Bible, Keith C.; Menefee, Michael E.; Lin, Chia-Chi (Josh); Millward, Michael J.; Maples, William J.; Goh, Boon Cher; Karlin, Nina J.; Kane, Madeleine A.; Adkins, Douglas R.; Molina, Julian R.; Donehower, Ross C.; Lim, Wan-Teck; Flynn, Patrick J.; Richardson, Ronald L.; Traynor, Anne M.; Rubin, Joseph; LoRusso, Patricia M.; Smallridge, Robert C.; Burton, Jill K.; Suman, Vera J.; Kumar, Aditi; Voss, Jessie S.; Rumilla, Kandalaria M.; Kipp, Benjamin R.; Chintakuntlawar, Ashish, V; Harris, Pamela; Erlichman, Charles

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency 错配修复缺陷肿瘤的PD-1阻断

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2015-06-25

7.7K

OAAI

Le, D. T.; Uram, J. N.; Wang, H.; Bartlett, B. R.; Kemberling, H.; Eyring, A. D.; Skora, A. D.; Luber, B. S.; Azad, N. S.; Laheru, D.; Biedrzycki, B.; Donehower, R. C.; Zaheer, A.; Fisher, G. A.; Crocenzi, T. S.; Lee, J. J.; Duffy, S. M.; Goldberg, R. M.; de la Chapelle, A.; Koshiji, M.; Bhaijee, F.; Huebner, T.; Hruban, R. H.; Wood, L. D.; Cuka, N.; Pardoll, D. M.; Papadopoulos, N.; Kinzler, K. W.; Zhou, S.; Cornish, T. C.; Taube, J. M.; Anders, R. A.; Eshleman, J. R.; Vogelstein, B.; Diaz, L. A., Jr.

Exposure-response analysis of rilotumumab in gastric cancer: the role of tumour MET expression

BRITISH JOURNAL OF CANCER

IF6.8

2015-01-13

OAAI

Zhu, M.; Tang, R.; Doshi, S.; Oliner, K. S.; Dubey, S.; Jiang, Y.; Donehower, R. C.; Iveson, T.; Loh, E. Y.; Zhang, Y.

A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours

BRITISH JOURNAL OF CANCER

IF6.8

2014-09-30

OAAI

Wilky, B. A.; Rudek, M. A.; Ahmed, S.; Laheru, D. A.; Cosgrove, D.; Donehower, R. C.; Nelkin, B.; Ball, D.; Doyle, L. A.; Chen, H.; Ye, X.; Bigley, G.; Womack, C.; Azad, N. S.

Interventions for preventing neuropathy caused by cisplatin and related compounds

COCHRANE DATABASE OF SYSTEMATIC REVIEWS

IF9.4

2014-03-31

OAAI

Albers, James W.; Chaudhry, Vinay; Cavaletti, Guido; Donehower, Ross C.

Correlation of Smad4 Status With Outcomes in Patients Receiving Erlotinib Combined With Adjuvant Chemoradiation and Chemotherapy After Resection for Pancreatic Adenocarcinoma

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2013-11-01

OAAI

Herman, Joseph M.; Fan, Katherine Y.; Wild, Aaron T.; Wood, Laura D.; Blackford, Amanda L.; Donehower, Ross C.; Hidalgo, Manuel; Schulick, Richard D.; Edil, Barish H.; Choti, Michael A.; Hruban, Ralph H.; Pawlik, Timothy M.; Cameron, John L.; Laheru, Daniel A.; Iacobuzio-Donahue, Christine A.; Wolfgang, Christopher L.

A Phase I trial of vertical inhibition of IGF signaling using IMC-A12, an IGF1-R inhibitor, and AZD6244, a MEK 1/2 inhibitor, in patients with advanced solid tumors.

MOLECULAR CANCER THERAPEUTICS

IF5.5

2013-11-01

PREAI

Wilky, Breelyn A.; Rudek, Michelle; Laheru, Daniel; Cosgrove, David; Donehower, Ross; Nelkin, Barry; Balls, Douglas; Doyle, L. Austin; Chen, Helen; Ye, Xiaobu; Azad, Nilofer

Incidence and Prognostic Impact of KRAS and BRAF Mutation in Patients Undergoing Liver Surgery for Colorectal Metastases

CANCER

IF5.1

2013-09-19

166

OAAI

Karagkounis, Georgios; Torbenson, Michael S.; Daniel, Hubert D.; Azad, Nilofer S.; Diaz, Luis A., Jr.; Donehower, Ross C.; Hirose, Kenzo; Ahuja, Nita; Pawlik, Timothy M.; Choti, Michael A.

Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer Ipilimumab与转染gm-csf基因的同种异体胰腺肿瘤细胞联合治疗胰腺癌的评估

JOURNAL OF IMMUNOTHERAPY

IF2.9

2013-09-01

505

OAAI

Le, Dung T.; Lutz, Eric; Uram, Jennifer N.; Sugar, Elizabeth A.; Onners, Beth; Solt, Sara; Zheng, Lei; Diaz, Luis A., Jr.; Donehower, Ross C.; Jaffee, Elizabeth M.; Laheru, Daniel A.

Phase 2 Study of Erlotinib Combined With Adjuvant Chemoradiation and Chemotherapy in Patients With Resectable Pancreatic Cancer

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2013-07-01

OAAI

Herman, Joseph M.; Fan, Katherine Y.; Wild, Aaron T.; Hacker-Prietz, Amy; Wood, Laura D.; Blackford, Amanda L.; Ellsworth, Susannah; Zheng, Lei; Le, Dung T.; De Jesus-Acosta, Ana; Hidalgo, Manuel; Donehower, Ross C.; Schulick, Richard D.; Edil, Barish H.; Choti, Michael A.; Hruban, Ralph H.; Pawlik, Timothy M.; Cameron, John L.; Laheru, Daniel A.; Wolfgang, Christopher L.

Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancer

INVESTIGATIONAL NEW DRUGS

IF2.7

2012-05-22

OAAI

Azad, Nilofer; Dasari, Arvind; Arcaroli, John; Taylor, Gretchen E.; Laheru, Daniel A.; Carducci, Michael A.; McManus, Martine; Quackenbush, Kevin; Wright, John J.; Hidalgo, Manuel; Diaz, Luis A., Jr.; Donehower, Ross C.; Zhao, Ming; Rudek, Michelle A.; Messersmith, Wells A.

Integrated preclinical and clinical development of S-trans, trans-farnesylthiosalicylic acid (FTS, Salirasib) in pancreatic cancer

INVESTIGATIONAL NEW DRUGS

IF2.7

2012-05-01

OAAI

Laheru, Daniel; Shah, Preeti; Rajeshkumar, N. V.; McAllister, Florencia; Taylor, Gretchen; Goldsweig, Howard; Le, Dung T.; Donehower, Ross; Jimeno, Antonio; Linden, Sheila; Zhao, Ming; Song, Dongweon; Rudek, Michelle A.; Hidalgo, Manuel

Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m2 every 21 days in patients with cancer I期剂量递增研究，以检查LY2603618的安全性和耐受性，一种检查点1激酶抑制剂，在培美曲塞500 mg/m2后1天，每21天给药一次，用于癌症患者

INVESTIGATIONAL NEW DRUGS

IF2.7

2012-04-11

OAAI

Weiss, Glen J.; Donehower, Ross C.; Iyengar, Tara; Ramanathan, Ramesh K.; Lewandowski, Karen; Westin, Eric; Hurt, Karla; Hynes, Scott M.; Anthony, Stephen P.; McKane, Scott

Safety and Efficacy of Epirubicin, Cisplatin, and Capecitabine (ECX) Plus Rilotumumab (R) as FIrst-line Treatment for Unresectable Locally Advanced (LA) or Metastatic (M) Gastric or Esophagogastric Junction (EGJ) Adenocarcinoma

EUROPEAN JOURNAL OF CANCER

IF7.1

2011-09-01

PREAI

Iveson, T.; Donehower, R. C.; Davidenko, I.; Tjulandin, S.; Deptala, A.; Harrison, M.; Loh, E.; Jiang, Y.; Oliner, K.; Dubey, S.

Interventions for preventing neuropathy caused by cisplatin and related compounds

COCHRANE DATABASE OF SYSTEMATIC REVIEWS

IF9.4

2011-02-16

138

OAAI

Albers, James W.; Chaudhry, Vinay; Cavaletti, Guido; Donehower, Ross C.

Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer

MOLECULAR CANCER THERAPEUTICS

IF5.5

2011-01-10

215

OAAI

Villarroel, Maria C.; Rajeshkumar, N. V.; Garrido-Laguna, Ignacio; De Jesus-Acosta, Ana; Jones, Sian; Maitra, Anirban; Hruban, Ralph H.; Eshleman, James R.; Klein, Alison; Laheru, Daniel; Donehower, Ross; Hidalgo, Manuel

Phase I Trial of Oxaliplatin, Infiisional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer

CLINICAL COLORECTAL CANCER

IF3.2

2010-12-01

OAAI

Messersmith, Wells A.; Jimeno, Antonio; Jacene, Heather; Zhao, Ming; Kulesza, Piotr; Laheru, Daniel A.; Kahn, Yasmin; Spira, Alexander; Dancey, Janet; Iacobuzio-Donahue, Christine; Donehower, Ross C.; Carducci, Michael; Rudek, Michelle A.; Hidalgo, Manuel

Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer

BRITISH JOURNAL OF CANCER

IF6.8

2010-07-27

OAAI

Garrido-Laguna, I.; Tan, A. C.; Uson, M.; Angenendt, M.; Ma, W. W.; Villaroel, M. C.; Zhao, M.; Rajeshkumar, N. V.; Jimeno, A.; Donehower, R.; Iacobuzio-Donahue, C.; Barrett, M.; Rudek, M. A.; Rubio-Viqueira, B.; Laheru, D.; Hidalgo, M.

Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer

INVESTIGATIONAL NEW DRUGS

IF2.7

2010-03-23

OAAI

Weekes, Colin D.; Nallapareddy, Sujatha; Rudek, Michelle A.; Norris-Kirby, Alexis; Laheru, Daniel; Jimeno, Antonio; Donehower, Ross C.; Murphy, Kathleen M.; Hidalgo, Manuel; Baker, Sharyn D.; Messersmith, Wells A.

研究方向